血红蛋白A1c作为全关节置换术后假体周围感染预测指标的有限效用:连续变量分析
该研究基于医疗数据库纳入2016至2021年行初次全髋或全膝关节置换且术前28天内有HbA1c值的17481例择期手术患者,采用限制性立方样条分析HbA1c连续值与术后90天假体周围感染(PJI)的关系,并计算敏感度和特异度。结果显示全膝关节置换PJI阈值为9.7%(敏感度19.4%,特异度99.1%),全髋关节置换为7.8%(敏感度22.7%,特异度89.9%);总医疗并发症阈值全膝为6.8%、全髋为6.5%;HbA1c与总手术并发症无关联。作者认为HbA1c对术后并发症预测效用有限,但仍可作为术前风险分层的可及生物标志物。
要点
- 全膝关节置换PJI的HbA1c阈值为9.7%,敏感度19.4%、特异度99.1%。
- 全髋关节置换PJI的HbA1c阈值为7.8%,敏感度22.7%、特异度89.9%。
- HbA1c与全髋或全膝关节置换的总手术并发症无关联。
核心结论
- 研究识别出PJI和医疗并发症的HbA1c阈值,高于该阈值的患者早期术后并发症风险显著增加。
- 作者认为HbA1c对术后并发症的预测效用有限,但仍是一种可及生物标志物,可辅助术前风险分层。
- 作者建议未来研究探索其他更有前景或互补的生物标志物以用于术前风险分层。
研究设计与样本
- 利用医疗数据库识别2016至2021年行初次全髋关节置换或全膝关节置换、且术前28天内有HbA1c值的患者。
- 共纳入17481例择期关节置换患者,术前HbA1c均值为6.5%。
- 主要结局为术后90天内PJI,次要结局为总医疗并发症和总手术并发症。
- 采用逻辑回归生成限制性立方样条,将HbA1c作为连续变量量化其对PJI风险的影响。
- 在HbA1c 5%至12%之间以0.5%为间隔计算相关敏感度和特异度,并用约登J统计量确定临床相关术前HbA1c阈值。
主要发现
- 全膝关节置换PJI阈值为9.7%(敏感度19.4%,特异度99.1%)。
- 全髋关节置换PJI阈值为7.8%(敏感度22.7%,特异度89.9%)。
- 总医疗并发症阈值全膝关节置换为6.8%(敏感度53.7%,特异度59.1%),全髋关节置换为6.5%(敏感度45.5%,特异度66.5%)。
- 全髋关节置换和全膝关节置换中,HbA1c与总手术并发症均无关联。
关键数值与推荐
- 全膝关节置换PJI阈值9.7%,敏感度19.4%,特异度99.1%。
- 全髋关节置换PJI阈值7.8%,敏感度22.7%,特异度89.9%。
- 全膝关节置换总医疗并发症阈值6.8%,敏感度53.7%,特异度59.1%。
- 全髋关节置换总医疗并发症阈值6.5%,敏感度45.5%,特异度66.5%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者在结论中指出HbA1c对术后并发症的预测效用有限。
- 作者在结论中提出未来研究应探索其他更有前景或互补的生物标志物以用于术前风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients who have poorly controlled diabetes mellitus are at increased risk of periprosthetic joint infection (PJI). Nevertheless, an optimal preoperative hemoglobin A1c (HbA1c) threshold has not been established. This study sought to identify preoperative HbA1c thresholds that were predictive of adverse outcomes for total hip arthroplasty (THA) and total knee arthroplasty (TKA) patients. METHODS: A healthcare database was used to identify primary THAs or TKAs performed from 2016 to 2021 with a preoperative HbA1c value within 28 days of surgery. The primary outcome was PJI within 90 days postoperatively. Secondary outcomes included aggregate medical and surgical complications. Restricted cubic splines were generated using logistic regression to quantify the impact of HbA1c as a continuous variable on the risk of PJI. Between HbA1c values of 5 and 12%, relevant sensitivity and specificity measurements were calculated at intervals of 0.5%. A Youden's J statistic identified clinically relevant preoperative HbA1c thresholds. RESULTS: In total, 17,481 elective arthroplasty patients who had a preoperative HbA1c were identified. The mean preoperative HbA1c was 6.5%. The previous two sentences should be placed at the end of the Methods section For TKA, a PJI threshold of 9.7% was identified (sensitivity: 19.4%, specificity: 99.1%), while for THA, a PJI threshold of 7.8% was identified (sensitivity: 22.7%, specificity: 89.9%). The threshold for aggregate medical complications was 6.8% for TKA (sensitivity: 53.7%, specificity: 59.1%) and 6.5% for THA (sensitivity: 45.5%, specificity: 66.5%). No association was observed between HbA1c and aggregate surgical complications for either THA or TKA. CONCLUSIONS: This study identified PJI and medical complication HbA1c thresholds above which patients were at a significantly increased risk of early postoperative complications. While our findings suggest that HbA1c has limited predictive utility for postoperative complications, it remains an accessible biomarker that can aid in preoperative risk stratification. Future studies should explore other promising or complementary biomarkers that may be more effective for preoperative risk stratification. LEVEL OF EVIDENCE: Level III.
引用
- Palmer RC, Telang SS, Ball JR, et al. The Limited Utility of Hemoglobin A1c as a Predictor for Periprosthetic Joint Infection Following Total Joint Arthroplasty: A Continuous Variable Analysis. J Arthroplasty. 2025. PMID: 39814114. doi:10.1016/j.arth.2025.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。